$6.25
-0.06-0.95%
Last update: 12:40 PM
15 minutes delayed
Comments
Loading...
Nuvectis Pharma (NVCT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNuvectis Pharma (NASDAQ:NVCT) Stock Quotes, Forecast and News Summary
Nuvectis Pharma Stock (NASDAQ: NVCT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Nuvectis Pharma (NVCT) stock?
You can purchase shares of Nuvectis Pharma (NASDAQ:NVCT) through any online brokerage.
Who are Nuvectis Pharma (NVCT) competitors?
Other companies in Nuvectis Pharma’s space includes: Skye Bioscience (NASDAQ:SKYE), Anixa Biosciences (NASDAQ:ANIX), Citius Oncology (NASDAQ:CTOR), Adicet Bio (NASDAQ:ACET) and Agenus (NASDAQ:AGEN).
What is the forecast, or price target, for Nuvectis Pharma (NVCT) stock?
Nuvectis Pharma has a consensus price target of $21.00.
What is the current price for Nuvectis Pharma (NVCT)?
The stock price for Nuvectis Pharma (NASDAQ: NVCT) is $6.26 last updated September 25, 2024 at 8:38 AM EDT.
Does Nuvectis Pharma (NVCT) pay a dividend?
There are no upcoming dividends for Nuvectis Pharma.
When is Nuvectis Pharma (NASDAQ:NVCT) reporting earnings?
Nuvectis Pharma’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Nuvectis Pharma (NVCT) going to split?
There is no upcoming split for Nuvectis Pharma.
What sector and industry does Nuvectis Pharma (NVCT) operate in?
Nuvectis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.